Skip to main content
. 2023 Nov 29;15(23):4955. doi: 10.3390/nu15234955

Table 4.

Comparison of practice frequency according to physical activity type and intensity of physical activity.

Variables Men p-Value
Sarcopenic Diabetes a (n = 126) Sarcopenia Alone b (n = 458) Diabetes Alone c (n = 135) Non-Sarcopenia
and Non-Diabetes d (n = 552)
n (%) n (%) n (%) n (%)
Flexibility exercise ≥ 2 days/week (yes) 48 (38.1) 160 (34.9) d 60 (44.4) 238 (43.1) b 0.04
Resistance training ≥ 2 days/week (yes) 26 (20.6) 87 (19.0) c,d 43 (31.9) b 155 (28.1) b <0.01
Moderate-intensity physical activity ≥ 150 min/week (yes) 29 (23.0) 109 (23.8) 38 (28.1) 161 (29.2) 0.19
Vigorous-intensity physical activity ≥ 75 min/week (yes) 11 (8.7) c,d 74 (16.2) c 40 (29.6) a,b 107 (19.4) a <0.01
Variables Women p-value
Sarcopenic diabetes a
(n = 71)
Sarcopenia alone b
(n = 312)
Diabetes alone c
(n = 249)
Non-sarcopenia
and non-diabetes d
(n = 1049)
n (%) n (%) n (%) n (%)
Flexibility exercise ≥ 2 days/week (yes) 17 (23.9) 98 (31.4) 89 (35.7) 311 (29.6) 0.16
Resistance training ≥ 2 days/week (yes) 7 (9.9) 20 (6.4) 15 (6.0) 82 (7.8) 0.57
Moderate-intensity physical activity ≥ 150 min/week (yes) 5 (7.0) d 58 (18.6) 51(20.5) 249 (23.7) a <0.01
Vigorous-intensity physical activity ≥ 75 min/week (yes) 5 (7.0) 34 (10.9) 29 (11.6) 149 (14.2) 0.16

Note: p-values are from the Chi-square test. Significantly different (p < 0.05) from the: a Sarcopenic diabetes group, b Sarcopenia alone group, c Diabetes alone group, and d Non-sarcopenia and non-diabetes group. Bonferroni post hoc analyses were used to identify any group difference. Each physical activity was set to 1 if it met the practice criteria, and 0 otherwise, n: number of participants.